A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
Public ClinicalTrials.gov record NCT01594723. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary purpose of this study is to measure the response rate in participants with the myeloproliferative neoplasms (MPNs), polycythemia vera (PV), essential thrombocythemia (ET), or myelofibrosis (MF) when treated with LY2784544, including those who have demonstrated an intolerance to, failure of primary response to, or have demonstrated disease progression while on ruxolitinib.
Study identification
- NCT ID
- NCT01594723
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 110 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 21, 2012
- Primary completion
- Mar 19, 2015
- Completion
- Nov 30, 2026
- Last update posted
- Jun 22, 2026
2012 – 2026
United States locations
- U.S. sites
- 23
- U.S. states
- 17
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Highlands Oncology Group - Duplicate 2 | Rogers | Arkansas | 72758 | — |
| Providence St. Joseph's Medical Center | Burbank | California | 91505 | — |
| Norwalk Hospital | Norwalk | Connecticut | 06856 | — |
| Lakeland Regional Cancer Center | Lakeland | Florida | 33805 | — |
| Palm Beach Cancer Institue | West Palm Beach | Florida | 33401 | — |
| Ingalls Memorial Hospital | Harvey | Illinois | 60426 | — |
| Indiana Blood & Marrow Transplantation (IBMT) | Indianapolis | Indiana | 46237 | — |
| Cancer Center of Kansas | Wichita | Kansas | 67214 | — |
| Greenebaum Comprehensive Cancer Center | Baltimore | Maryland | 21201 | — |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | — |
| Washington University Medical Center | St Louis | Missouri | 63110 | — |
| Nebraska Methodist Hospital | Omaha | Nebraska | 68114 | — |
| Weill Cornell Medical College | New York | New York | 10021 | — |
| Albert Einstein College of Medicine | The Bronx | New York | 10461 | — |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| Mid Ohio Oncology Hematology | Columbus | Ohio | 43219 | — |
| Baptist Cancer Center | Memphis | Tennessee | 38120 | — |
| Sarah Cannon Cancer Center | Nashville | Tennessee | 37203 | — |
| Tennessee Oncology PLLC | Nashville | Tennessee | 37203 | — |
| Joe Arrington Cancer Center | Lubbock | Texas | 79410 | — |
| Swedish Medical Center | Seattle | Washington | 98104 | — |
| Dean Medical Center | Madison | Wisconsin | 53717 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01594723, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 22, 2026 · Synced Sep 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01594723 live on ClinicalTrials.gov.